Global Top 10 Drug Delivery Technologies Market Size to reach USD 111.5 billion by 2026 | Elan Corporation, Alkermes Inc., Altea Therapeutics Inc., Antares Pharma Inc., A.P. Pharma Inc., Applied Pharma, Aradigm Corporation, Baxter Biopharma, Becton, Dicki
Global Top 10 Drug Delivery Technologies Market is valued approximately USD 111.5 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 11% over the forecast period 2019-2026. Drug delivery is a methodology or method of administering a pharmaceutical compound to attain a therapeutic impact in humans or animals.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2496517/?utm_source=openpr.com/&utm_medium=VSD
The regional analysis of global Top 10 Drug Delivery Technologies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to various technological innovation such as drug polymer conjugates. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising disposable income, rising patent awareness levels and improving healthcare infrastructure would create lucrative growth prospects for the Top 10 Drug Delivery Technologies market across Asia-Pacific region.
As per the FDA products module in 2018 the approvals according to the delivery route by the FDA increased by 35% for injections amounting to 40 apporvals, while the oral drig delivery approvals amounted to 59 an increase of 52%. Moreover, home-care drug delivery devices & self-administration is expected to create significant growth opportunity in the market over the forecast period. However, drug failures and technical barriers impede the growth of the market over the forecast period of 2019-2026.
Growing need for effective delivery of novel biopharmaceuticals and pharmaceutical coupled with innovation in drug delivery technologies are key driving forces of market. Apart from this, patent expiration of drugs coupled with innovations in drug delivery technologies are further contributing towards market growth.
Drug delivery systems are built technologies for the targeted delivery and/or controlled unharness of therapeutic agents. Medicines have long been accustomed to improve health and extend lives. Drug delivery technologies enhance the drug life cycle through extending patent rights and also enhance drug safety and efficacy.
Major market player included in this report are:
o Elan Corporation
o Alkermes, Inc
o Altea Therapeutics Inc.
o Antares Pharma Inc.
o A.P. Pharma, Inc.
o Applied Pharma
o Aradigm Corporation
o Baxter Biopharma
o Becton, Dickinson And Company
o Bioject Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market.
Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Delivery Technologies:
o Oral Time Release/Sustained Release
o Targeted Delivery
o North America
o Asia Pacific
o Latin America
o Rest of the World
Furthermore, years considered for the study are as follows:
o Historical year - 2016, 2017
o Base year - 2018
o Forecast period - 2019 to 2026
Target Audience of the Global Top 10 Drug Delivery Technologies Market in Market Study:
o Key Consulting Companies & Advisors
o Large, medium-sized, and small enterprises
o Venture capitalists
o Value-Added Resellers (VARs)
o Third-party knowledge providers
o Investment bankers
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2496517/?utm_source=openpr.com/&utm_medium=VSD
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Top 10 Drug Delivery Technologies Market, by Region, 2017-2026 (USD Billion)
1.2.2. Top 10 Drug Delivery Technologies Market, by Drug Delivery Technologies, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Top 10 Drug Delivery Technologies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Top 10 Drug Delivery Technologies Market Dynamics
3.1. Top 10 Drug Delivery Technologies Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Top 10 Drug Delivery Technologies Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
Flu Vaccine Market Share 2020-2025 | Global Industry Report.
As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy of existing vaccines, and launch of new vaccines are driving the growth of flu vaccine market. Flu or influenza is a highly transmissible disease, spreading through coughs and sneezes of the infected person.
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Top 10 Drug Delivery Technologies Market Size to reach USD 111.5 billion by 2026 | Elan Corporation, Alkermes Inc., Altea Therapeutics Inc., Antares Pharma Inc., A.P. Pharma Inc., Applied Pharma, Aradigm Corporation, Baxter Biopharma, Becton, Dicki here
News-ID: 2023459 • Views: 443
More Releases from marketstudyreport.com
Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning